AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.060
-0.010 (-0.25%)
At close: Jun 18, 2026, 4:00 PM EDT
4.020
-0.040 (-0.99%)
After-hours: Jun 18, 2026, 7:59 PM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.49 billion as of June 18, 2026. Its market cap has increased by 187.72% in one year.
Market Cap
1.49B
Enterprise Value
1.27B
1-Year Change
187.72%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.49B, a decrease of -34.69%. That is a compound annual growth rate of -8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.49B | 0.62% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.57B |
| Monte Rosa Therapeutics | 1.57B |
| Novavax | 1.53B |
| Vir Biotechnology | 1.52B |
| Ascentage Pharma Group International | 1.50B |
| Fortrea Holdings | 1.47B |
| Bicara Therapeutics | 1.47B |
| Ardelyx | 1.46B |